Application of recombinant protein technologies in the development of innovative medical devices for BV treatment (Q3798321): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr: translated_label) |
(Changed label, description and/or aliases in de: translated_label) |
||
| label / de | label / de | ||
Anwendung rekombinanter Proteintechnologien bei der Entwicklung innovativer Medizinprodukte für die BV-Behandlung | |||
Revision as of 12:33, 1 December 2021
Project Q3798321 in Lithuania
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Application of recombinant protein technologies in the development of innovative medical devices for BV treatment |
Project Q3798321 in Lithuania |
Statements
1,110,770.11 Euro
0 references
Uždaroji akcinė bendrovė "Profarma"
0 references
Identifiers
J05-LVPA-K-04-0085
0 references